Search - tctmd.com

Displaying 961 - 980 of 1255

Sort: Relevancy | Date

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Daily News

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

L.A. McKeown

November 21, 2017

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

Todd Neale

November 12, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

Quantitative Flow Ratio Shows Potential in Cath Lab

TCT Daily Staff

November 03, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Caitlin E. Cox

October 24, 2017

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Todd Neale

October 02, 2017

Advertisement

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Routine Coronary CTA to Rule Out ACS in Acute Chest Pain Questioned in ROMICAT-II Subanalysis

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Quantitative Flow Ratio Shows Potential in Cath Lab

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Off Script: Focusing on the Future

Off Script: Welcome to TCT 2017 in the Mile High City

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content